BioSpace News Archive

Gracell Biotechnologies Inc. announced the details of its poster presentation at the American Association for Cancer Research Annual Meeting 2022, being held from April 8-13 in New Orleans, Louisiana.

Phio Pharmaceuticals Corp. (Nasdaq: PHIO), today announced that it is scheduled to present new preclinical data on PH-894, Phio’s self-delivering RNAi compound targeting the bromodomain-containing protein 4 (BRD4), in an in-person poster session at the AACR Annual Meeting 2022.

Eli Lilly and Company announced that data from the pirtobrutinib and Verzenio® development programs will be presented at the 2022 American Association for Cancer Research Annual Meeting, April 8 - 13, 2022.

Boston Scientific Corporation announced that American Medical Systems Europe B.V., its wholly owned finance subsidiary, has completed a public offering of €1,000,000,000 aggregate principal amount of 0.750% notes due 2025, €750,000,000 aggregate principal amount of 1.375% notes due 2028, €750,000,000 aggregate principal amount of 1.625% notes due 2031 and €500,000,000 aggregate principal amount of 1.875% notes due 2034.